RU99102760A - METHOD FOR TREATING UTERINE BODY CANCER - Google Patents

METHOD FOR TREATING UTERINE BODY CANCER

Info

Publication number
RU99102760A
RU99102760A RU99102760/14A RU99102760A RU99102760A RU 99102760 A RU99102760 A RU 99102760A RU 99102760/14 A RU99102760/14 A RU 99102760/14A RU 99102760 A RU99102760 A RU 99102760A RU 99102760 A RU99102760 A RU 99102760A
Authority
RU
Russia
Prior art keywords
uterine body
body cancer
treating uterine
opk
tamoxifen
Prior art date
Application number
RU99102760/14A
Other languages
Russian (ru)
Inventor
С.Я. Максимов
Б.В. Васильев
А.Т. Волкова
О.Ф. Чепик
А.С. Вишневский
Original Assignee
НИИ онкологии им. проф. Н.Н.Петрова
Filing date
Publication date
Application filed by НИИ онкологии им. проф. Н.Н.Петрова filed Critical НИИ онкологии им. проф. Н.Н.Петрова
Publication of RU99102760A publication Critical patent/RU99102760A/en

Links

Claims (1)

Способ лечения рака тела матки первичных больных молодого возраста, включающий гормонотерапию, отличающийся тем, что лечение проводят по схеме: ОПК+тамоксифен в дозах: ОПК 500 мг ежедневно в течение 3 месяцев, 1 тамоксифен 20 мг ежедневно.A method of treating uterine body cancer of primary patients of young age, including hormone therapy, characterized in that the treatment is carried out according to the scheme: OPK + tamoxifen in doses: OPK 500 mg daily for 3 months, 1 tamoxifen 20 mg daily.
RU99102760/14A 1999-02-09 METHOD FOR TREATING UTERINE BODY CANCER RU99102760A (en)

Publications (1)

Publication Number Publication Date
RU99102760A true RU99102760A (en) 2000-12-10

Family

ID=

Similar Documents

Publication Publication Date Title
IL151164A0 (en) Azacyclic compounds for use in the treatment of serotonin related diseases
EG25822A (en) Quinolinyl-pyrrolopyrazoles
DE60026538D1 (en) PHARMACEUTICAL PREPARATIONS THE CLAVULANIC ACID OR DERIVATIVES CONTAIN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
HRP20080598T3 (en) Combination of et-743 with 5-fluorouracil pro-drugs for the treatment of cancer
MY164077A (en) Compositions and uses of et743 for treating cancer
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
HUP0202776A2 (en) Use of (+)-tramadol, o-demethyltramadol or(+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for preparation pharmaceutical composition available for treating urinary incontinence
DE60116075D1 (en) TREATMENT OF TUMORS WITH PHOTODYNAMIC THERAPY
PE20031047A1 (en) TREATMENT OF POST-MENOPAUSAL PATIENTS IN PATIENTS WITH BREAST CANCER
RU2002129355A (en) APPLICATION OF FULVESTRANTS IN TREATMENT OF RESISTANT BREAST CANCER
WO2000057867A3 (en) Improved cancer treatment with temozolomide
MXPA00010254A (en) The treatment of sexual dysfunction in certain patient groups.
RU99102760A (en) METHOD FOR TREATING UTERINE BODY CANCER
TR200401810T4 (en) Use of fsh for infertility treatment
IL159770A0 (en) Calcium salts with cytotoxic activity
EE200200549A (en) Split dose therapy with vascular damaging activity
IL101163A (en) Use of flunarizine in the preparation of medicaments for treating neoplastic diseases
CY1109852T1 (en) CALCIUM SUPPLEMENT FOR LIMITATION OF PROTECTOR CANCER RISK
RU99116652A (en) METHOD FOR TREATING MALIGNANT SKIN LYMPHOMA
ATE206056T1 (en) THERAPEUTIC AGENT FOR NEUTROPENIA
RU98105539A (en) METHOD FOR TREATING PSORIASIS
GEP19991781B (en) Means for Treatment of Prostate Diseases
RU99122488A (en) METHOD FOR TREATING CANCER ENDOMETRY
UA28644A (en) Method of the treatment of a primary amenorrhea of the central genesis in the girls-teenagers
RU2002103977A (en) A method for the treatment of acute purulent pyelonephritis